Thermo Fisher Scientific USP7 Polyclonal Antibody
상품 옵션 정보 | ||||||||
---|---|---|---|---|---|---|---|---|
카탈로그 번호 | CAS 번호 | 설명 | 상태 | 단위 | 판매가 | 할인가 | 가격(VAT포함) | 수량 / 장바구니 / 찜 |
PA589302 | - | Thermo Fisher Scientific PA589302 USP7 Polyclonal Antibody 100 ul pk | 재고문의 | pk | 621,000원 | - | 683,100원 |
다른 상품 둘러보기
Applications
Tested Dilution
Publications
Western Blot (WB)
1:500-1:2,000
Immunohistochemistry (Paraffin) (IHC (P))
1:50-1:200
Immunocytochemistry (ICC/IF)
1:50-1:200
ELISA (ELISA)
1 µg/mL
Product Specifications
Species Reactivity
Human, Mouse, Rat
Host/Isotype
Rabbit / IgG
Class
Polyclonal
Type
Antibody
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 206-1102 of human USP7/HAUSP (NP_0034612) if (typeof window.$mangular === undefined
|| !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{
targetFamily:
USP7,
uniProtId:
Q93009-1,
ncbiNodeId:
9606,
antigenRange:
206-1102,
antigenLength:
1102,
antigenImageFileName:
PA5-89302_USP7_Q93009-1_Rabbit.svg,
antigenImageFileNamePDP:
PA5-89302_USP7_Q93009-1_Rabbit_PDP.jpeg,
sortOrder:
1}\]
; $mangular.isB2BCMGT = false
; $mangular.isEpitopesModalImageMultiSizeEnabled = true
;
View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}
Conjugate
Unconjugated Unconjugated Unconjugated
Form
Liquid
Concentration
3.53 mg/mL
Purification
Affinity Chromatography
Storage buffer
PBS, pH 7.3, with 50% glycerol
Contains
0.02% sodium azide
Storage conditions
-20° C, Avoid Freeze/Thaw Cycles
Shipping conditions
Wet ice
RRID
AB_2805479
Product Specific Information
Immunogen sequence: DSKKHTGYVG LKNQGATCYM NSLLQTLFFT NQLRKAVYMM PTEGDDSSKS VPLALQRVFY ELQHSDKPVG TKKLTKSFGW ETLDSFMQHD VQELCRVLLD NVENKMKGTC VEGTIPKLFR GKMVSYIQCK EVDYRSDRRE DYYDIQLSIK GKKNIFESFV DYVAVEQLDG DNKYDAGEHG LQEAEKGVKF LTLPPVLHLQ LMRFMYDPQT DQNIKINDRF EFPEQLPLDE FLQKTDPKDP ANYILHAVLV HSGDNHGGHY VVYLNPKGDG KWCKFDDDVV SRCTKEEAIE HNYGGHDDDL SVRHCTNAYM LVYIRESKLS EVLQAVTDHD IPQQLVERLQ EEKRIEAQKR KERQEAHLYM QVQIVAEDQF CGHQGNDMYD EEKVKYTVFK VLKNSSLAEF VQSLSQTMGF PQDQIRLWPM QARSNGTKRP AMLDNEADGN KTMIELSDNE NPWTIFLETV DPELAASGAT LPKFDKDHDV MLFLKMYDPK TRSLNYCGHI YTPISCKIRD LLPVMCDRAG FIQDTSLILY EEVKPNLTER IQDYDVSLDK ALDELMDGDI IVFQKDDPEN DNSELPTAKE YFRDLYHRVD VIFCDKTIPN DPGFVVTLSN RMNYFQVAKT VAQRLNTDPM LLQFFKSQGY RDGPGNPLRH NYEGTLRDLL QFFKPRQPKK LYYQQLKMKI TDFENRRSFK CIWLNSQFRE EEITLYPDKH GCVRDLLEEC KKAVELGEKA SGKLRLLEIV SYKIIGVHQE DELLECLSPA TSRTFRIEEI PLDQVDIDKE NEMLVTVAHF HKEVFGTFGI PFLLRIHQGE HFREVMKRIQ SLLDIQEKEF EKFKFAIVMM GRHQYINEDE YEVNLKDFEP QPGNMSHPRP WLGLDHFNKA PKRSRYTYLE KAIKIHN; Positive Samples: HepG2, Rat testis; Cellular Location: Cytoplasm, Nucleus, PML body
Target Information
USP7 or HAUSP is a ubiquitin specific protease or a deubiquitylating enzyme that cleaves ubiquitin from its substrates. Since ubiquitylation (polyubiquitination) is most commonly associated with the stability and degradation of cellular proteins, HAUSP activity generally stabilizes its substrate proteins. HAUSP is most popularly known as a direct antagonist of Mdm2, the E3 ubiquitin ligase for the tumor suppressor protein, p53. Normally, p53 levels are kept low in part due to Mdm2-mediated ubiquitylation and degradation of p53. Interestingly, in response to oncogenic insults, HAUSP can deubiquitinate p53 and protect p53 from Mdm2-mediated degradation, indicating that it may possess a tumor suppressor function for the immediate stabilization of p53 in response to stress. Another important role of HAUSP function involves the oncogenic stabilization of p53. Oncogenes such as Myc and E1A are thought to activate p53 through a p19 alternative reading frame (p19ARF, also called ARF)-dependent pathway, although some evidence suggests ARF is not essential in this process. An intriguing possibility is that HAUSP provides an alternative pathway for safeguarding the cell against oncogenic insults.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
배송/결제/교환/반품 안내
배송 정보
기본 배송비 |
| 교환/반품 배송비 |
|
---|---|---|---|
착불 배송비 |
| ||
교환/반품 배송비 |
|
결제 및 환불 안내
결제 방법 |
|
---|---|
취소 |
|
반품 |
|
환급 |
|
교환 및 반품 접수
교환 및 반품 접수 기한 |
|
---|---|
교환 및 반품 접수가 가능한 경우 |
|
교환 및 반품 접수가 불가능한 경우 |
|
교환 및 반품 신청
교환 절차 |
|
---|---|
반품 절차 |
|